Product Images Quillivant XR

NextWave Pharmaceuticals, Inc. is a pharmaceutical company.*

This text provides a table with the mean d-Methylphenidate plasma concentration (in ng/mL) over a period of time (up to 35 hours) for Quillivant 60mg and Methylphenidate IR Oral Solution at a dosage of 2x30 mg every 6 hours.*

This text is a product description for Quillivant XR, which is a methylphenidate hydrochloride medication for attention deficit hyperactivity disorder (ADHD). It comes in an oral suspension form. The medication must be reconstituted with 53 mL of water before dispensing, and the pharmacist should provide the enclosed medication guide to each patient. The medication should be shaken well for at least 10 seconds before each use. The total volume of the medication is 300 mg/60 mL. When reconstituted it has a concentration of 25 mg/5 mL (5 mg/mL). It contains both English and non-English characters.*

Quillivant XR is an extended-release oral suspension of methylphenidate HCI. It is available as a 25mg/5mL solution and must be reconstituted with 105mL of water prior to dispensing. The solution should be shaken well for at least 10 seconds before each use. It is important to keep the medication out of reach of children.*

This appears to be a graph or chart comparing the Mean Combined SKAMP Score + SE of a medication called Quillivant versus a placebo over a period of time measured in hours. However, without more context or information, it is difficult to provide a more detailed or accurate description.*

NextWave Pharmaceuticals, Inc. is a pharmaceutical company.*

NextWave Pharmaceuticals, Inc is a pharmaceutical company.*